Webinar - Diversity in Clinical Trials A more inclusive approach in patient recruitment

Webinar Synopsis

We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient recruitment.

Between 2008 and 2018, fewer than two in three (63%) of the 230 clinical trials that led to cancer drug approvals by the Food and Drug Administration (FDA) in the US, recorded participants’ ethnicity. This lack of diversity is a major issue: studies show that different groups can respond to treatments in various ways, resulting in some medicines being prescribed differently.

This session will highlight some of the factors underpinning the lack of patient diversity in clinical trials, investigate the implications this has for patients, and discuss what we can do in practice to improve diversity in clinical trials.

Learning Objectives:

- What are the factors behind the lack of representations in clinical trials?
- What are the consequences of the lack of diversity in CT for patients?
- How do we improve diversity in clinical trials in practice?

Speakers:
Kate Shaw - Founder/CEO - Innovative Trials
Sandra Amro - Global Clinical Trial Diversity Team Lead- Pfizer
Jane Thurston - Senior Patient Recruitment Lead - Parexel